3 citations
,
October 2022 in “International Journal of Dermatology” This multicenter study found that hair and nail disorders, particularly telogen effluvium, commonly developed in patients after severe COVID-19 infection.
58 citations
,
November 2020 in “International Journal of Dermatology” COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.
January 2025 in “International Journal of Trichology” This retrospective study observed that telogen effluvium, a type of diffuse hair loss, frequently occurs in females aged 18–30 following SARS-CoV-2 infection, often accompanied by nutritional deficiencies, suggesting an association between COVID-19 and micronutrient deficiency, with acute cases being most common but chronic cases possible.
This study observed that post-COVID patients, especially females, commonly experience Telogen Effluvium, with earlier onset and increased trichodynia in those with more severe COVID-19.
2 citations
,
July 2021 in “Dermatologic Therapy” This case study reports a 58-year-old woman experiencing pressure-induced alopecia with concomitant acute telogen effluvium after severe COVID-19, suggesting a potential link between prolonged hospitalization and hair loss.